Brachytherapy Market Overview, Analysis and expected to boost growth

Brachytherapy is a type of radiotherapy that is used to treat cancers of all types. Internal radiation, or seed therapy, is another name for it. Unlike external beam radiotherapy, which distributes radiation from the outside, brachytherapy precisely targets the dangerous tumour from the inside. Radioactive seeds are implanted into malignant tissue and positioned in such a way that they will most effectively destroy the tumour. The use of brachytherapy to target malignant cells decreases the danger of harm to healthy tissues and organs surrounding the tumour, as well as the possibility of adverse effects. Brachytherapy is used to treat malignancies of the prostate, cervix, breast, and skin, as well as tumours in other parts of the body such the head and neck. Furthermore, it is frequently used in conjunction with chemotherapy medications to reduce the chance of cancer recurrence. Permanent and temporary brachytherapy are the two types of brachytherapy.

Rising prevalence of prostate cancer is expected to boost growth of the brachytherapy market

The brachytherapy industry is primarily driven by the rising incidence of prostate cancer occurrences. According to the American Cancer Society, around 161,370 people in the United States were diagnosed with prostate cancer in 2017, with approximately 26,730 deaths related to prostate cancer. In the United States, prostate cancer is the third greatest cause of death among males. The expanding acceptance of high dose rate brachytherapy and the rising prevalence of obesity are two key reasons driving the brachytherapy industry forward. However, radiation therapy side effects such as hair loss, fatigue, appetite loss, and nausea are likely to stifle the brachytherapy market's expansion.

Brachytherapy Market